| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.01. | UBS erhöht Kursziel für Aveanna Healthcare nach Prognoseanhebung auf 10 US-Dollar | 3 | Investing.com Deutsch | ||
| 15.01. | Aveanna Healthcare stock rises as RBC Capital raises price target on guidance | 1 | Investing.com | ||
| 15.01. | Aveanna Healthcare: Aktie steigt nach Prognoseanhebung und Kurszielerhöhung durch RBC Capital | 4 | Investing.com Deutsch | ||
| 14.01. | Aveanna rises as full-year revenue outlook exceeds consensus | 4 | Seeking Alpha | ||
| 14.01. | Aveanna Healthcare raises 2025 revenue guidance, issues 2026 outlook | 2 | Investing.com | ||
| 14.01. | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | 184 | GlobeNewswire (Europe) | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| 14.01. | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| AVEANNA HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 19.12.25 | 3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD | 2 | Zacks | ||
| 08.12.25 | William Blair initiates Aveanna Healthcare stock with Outperform rating | 3 | Investing.com | ||
| 08.12.25 | William Blair nimmt Aveanna Healthcare mit "Outperform"-Rating in die Bewertung auf | 1 | Investing.com Deutsch | ||
| 05.12.25 | Aveanna Healthcare stock price target raised to $13 by Raymond James | 3 | Investing.com | ||
| 14.11.25 | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.11.25 | Aveanna Healthcare: RBC Kapital bestätigt "Sektor Perform"-Rating und Kursziel von 10 US-Dollar | 1 | Investing.com Deutsch | ||
| 10.11.25 | Aveanna Healthcare stock holds steady as RBC maintains Sector Perform rating | 2 | Investing.com | ||
| 06.11.25 | Aveanna outlines 2025 revenue target above $2.375B while expanding preferred payer strategy and integration of Thrive | 1 | Seeking Alpha | ||
| 06.11.25 | Aveanna Healthcare Holdings Non-GAAP EPS of $0.15 beats by $0.01, revenue of $621.9M beats by $30.72M | 3 | Seeking Alpha | ||
| 06.11.25 | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | 255 | GlobeNewswire (Europe) | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| 06.11.25 | Aveanna Healthcare Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.11.25 | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.11.25 | Can Aveanna Drive a Strong Third Quarter on Care-Delivery Momentum? | 2 | Zacks |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SENSUS HEALTHCARE | 4,080 | -0,97 % | Übernahme führt zu Prüferwechsel bei Sensus Healthcare | ||
| BRIGHTSPRING HEALTH SERVICES | 38,360 | 0,00 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| SIEMENS HEALTHINEERS | 40,830 | -4,15 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| HEARTFLOW | 25,970 | -7,71 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,660 | +0,44 % | Fresenius Medical Care AG: Das Übergangsjahr 2026 rückt zunehmend in den Fokus. KAUFEN. | Die jüngste Konsensaktualisierung von Fresenius Medical Care lenkt den Fokus auf das Geschäftsjahr 2026 als ein Übergangsjahr. Die Markterwartungen deuten auf eine schrittweise operative Erholung hin... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,400 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,150 | 0,00 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| GENEDX | 84,08 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 21,920 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,500 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| FRESENIUS | 49,240 | 0,00 % | Fresenius: Analysten bleiben bullish - jetzt einsteigen? | Der charttechnische Ausflug der Aktie des Gesundheitskonzerns Fresenius über die Marke von 50 Euro war nicht nachhaltig. Inzwischen notiert der DAX-Wert wieder deutlich darunter. Geht es nach dem Gros... ► Artikel lesen | |
| CLEARPOINT NEURO | 12,570 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,080 | -0,95 % | Brenntag, Carl Zeiss Meditec, Evonik, Hypoport, Porsche, TeamViewer: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ADAPTHEALTH | 10,490 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| LIFESTANCE HEALTH GROUP | 6,545 | 0,00 % | LifeStance Health Gr Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) |